The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InIM Cannabis Corp. (IMCC) announced its audited financial results for the full year 2025, marking a significant milestone in its operational and financial efficiency. The company reported total revenue of C$54.7 million, underpinned by an impressive 134% growth in its German operations. A key highlight of the report was the achievement of a positive operating cash flow of C$4.7 million, representing a major turnaround from the negative figures recorded in 2024. This financial recovery was further supported by successful financing transactions that bolstered the company's cash position and balance sheet stability. Management attributed the strong performance to the expansion of the medical cannabis market in Germany and optimized cost structures. The transition to profitability at the operating level positions IMCC favorably within the competitive global cannabis sector.